Microbio Co Ltd (4128) - Net Assets
Based on the latest financial reports, Microbio Co Ltd (4128) has net assets worth NT$10.20 Billion TWD (≈ $321.50 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$12.33 Billion ≈ $388.58 Million USD) and total liabilities (NT$2.13 Billion ≈ $67.09 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 4128 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$10.20 Billion |
| % of Total Assets | 82.74% |
| Annual Growth Rate | 16.51% |
| 5-Year Change | -26.29% |
| 10-Year Change | 21.3% |
| Growth Volatility | 51.31 |
Microbio Co Ltd - Net Assets Trend (2006–2025)
This chart illustrates how Microbio Co Ltd's net assets have evolved over time, based on quarterly financial data. See 4128 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Microbio Co Ltd (2006–2025)
The table below shows the annual net assets of Microbio Co Ltd from 2006 to 2025. For live valuation and market cap data, see 4128 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | NT$10.20 Billion ≈ $321.50 Million |
-14.02% |
| 2024-12-31 | NT$11.87 Billion ≈ $373.94 Million |
-12.08% |
| 2023-12-31 | NT$13.50 Billion ≈ $425.34 Million |
-3.63% |
| 2022-12-31 | NT$14.01 Billion ≈ $441.34 Million |
+1.19% |
| 2021-12-31 | NT$13.84 Billion ≈ $436.15 Million |
+7.71% |
| 2020-12-31 | NT$12.85 Billion ≈ $404.91 Million |
+42.13% |
| 2019-12-31 | NT$9.04 Billion ≈ $284.89 Million |
-6.57% |
| 2018-12-31 | NT$9.68 Billion ≈ $304.91 Million |
+16.59% |
| 2017-12-31 | NT$8.30 Billion ≈ $261.53 Million |
-1.33% |
| 2016-12-31 | NT$8.41 Billion ≈ $265.04 Million |
-5.94% |
| 2015-12-31 | NT$8.94 Billion ≈ $281.77 Million |
-1.71% |
| 2014-12-31 | NT$9.10 Billion ≈ $286.68 Million |
+4.53% |
| 2013-12-31 | NT$8.70 Billion ≈ $274.25 Million |
+37.76% |
| 2012-12-31 | NT$6.32 Billion ≈ $199.08 Million |
+1.37% |
| 2011-12-31 | NT$6.23 Billion ≈ $196.39 Million |
+23.71% |
| 2010-12-31 | NT$5.04 Billion ≈ $158.75 Million |
-4.19% |
| 2009-12-31 | NT$5.26 Billion ≈ $165.69 Million |
+193.11% |
| 2008-12-31 | NT$1.79 Billion ≈ $56.53 Million |
+38.62% |
| 2007-12-31 | NT$1.29 Billion ≈ $40.78 Million |
+131.39% |
| 2006-12-31 | NT$559.40 Million ≈ $17.62 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Microbio Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 73557400000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | NT$9.65 Billion | 108.25% |
| Total Equity | NT$8.91 Billion | 100.00% |
Microbio Co Ltd Competitors by Market Cap
The table below lists competitors of Microbio Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ganesha Ecosphere Limited
NSE:GANECOS
|
$273.38 Million |
|
Te Chang Construction Co Ltd
TWO:5511
|
$273.41 Million |
|
Chien Kuo Construction Co Ltd
TW:5515
|
$273.43 Million |
|
Bera Holding AS
IS:BERA
|
$273.45 Million |
|
PT Estee Gold Feet Tbk
JK:EURO
|
$273.31 Million |
|
Bhansali Engineering Polymers Limited
NSE:BEPL
|
$273.28 Million |
|
Akebia Ther
NASDAQ:AKBA
|
$273.24 Million |
|
Highlight Tech
TWO:6208
|
$273.20 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Microbio Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 10,305,542,000 to 8,913,647,000, a change of -1,391,895,000 (-13.5%).
- Net loss of 757,746,000 reduced equity.
- Other factors decreased equity by 634,149,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$-757.75 Million | -8.5% |
| Other Changes | NT$-634.15 Million | -7.11% |
| Total Change | NT$- | -13.51% |
Book Value vs Market Value Analysis
This analysis compares Microbio Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.97x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.80x to 0.97x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | NT$3.88 | NT$14.75 | x |
| 2007-12-31 | NT$8.08 | NT$14.75 | x |
| 2008-12-31 | NT$6.09 | NT$14.75 | x |
| 2009-12-31 | NT$15.38 | NT$14.75 | x |
| 2010-12-31 | NT$10.36 | NT$14.75 | x |
| 2011-12-31 | NT$10.96 | NT$14.75 | x |
| 2012-12-31 | NT$11.05 | NT$14.75 | x |
| 2013-12-31 | NT$15.33 | NT$14.75 | x |
| 2014-12-31 | NT$13.88 | NT$14.75 | x |
| 2015-12-31 | NT$13.64 | NT$14.75 | x |
| 2016-12-31 | NT$12.86 | NT$14.75 | x |
| 2017-12-31 | NT$13.74 | NT$14.75 | x |
| 2018-12-31 | NT$13.04 | NT$14.75 | x |
| 2019-12-31 | NT$12.32 | NT$14.75 | x |
| 2020-12-31 | NT$20.40 | NT$14.75 | x |
| 2021-12-31 | NT$21.79 | NT$14.75 | x |
| 2022-12-31 | NT$21.60 | NT$14.75 | x |
| 2023-12-31 | NT$21.08 | NT$14.75 | x |
| 2024-12-31 | NT$17.52 | NT$14.75 | x |
| 2025-12-31 | NT$15.15 | NT$14.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Microbio Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -8.50%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -40.01%
- • Asset Turnover: 0.15x
- • Equity Multiplier: 1.38x
- Recent ROE (-8.50%) is below the historical average (-2.07%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | -4.31% | -10.40% | 0.29x | 1.43x | NT$-80.02 Million |
| 2007 | -9.54% | -79.32% | 0.09x | 1.34x | NT$-252.87 Million |
| 2008 | 1.80% | 5.06% | 0.23x | 1.57x | NT$-118.18 Million |
| 2009 | -1.88% | -11.08% | 0.13x | 1.36x | NT$-516.92 Million |
| 2010 | 8.68% | 38.23% | 0.20x | 1.16x | NT$-62.64 Million |
| 2011 | 5.56% | 23.47% | 0.18x | 1.32x | NT$-223.88 Million |
| 2012 | -0.67% | -2.83% | 0.16x | 1.45x | NT$-533.21 Million |
| 2013 | -1.75% | -11.06% | 0.12x | 1.29x | NT$-866.66 Million |
| 2014 | -1.81% | -10.04% | 0.14x | 1.26x | NT$-916.92 Million |
| 2015 | -2.53% | -12.75% | 0.15x | 1.29x | NT$-958.29 Million |
| 2016 | -3.70% | -17.59% | 0.16x | 1.28x | NT$-991.05 Million |
| 2017 | 7.03% | 38.44% | 0.15x | 1.19x | NT$-229.42 Million |
| 2018 | -9.42% | -47.69% | 0.14x | 1.40x | NT$-1.42 Billion |
| 2019 | -3.94% | -18.05% | 0.15x | 1.50x | NT$-935.56 Million |
| 2020 | 4.89% | 32.46% | 0.11x | 1.31x | NT$-542.98 Million |
| 2021 | -1.96% | -13.08% | 0.12x | 1.26x | NT$-1.42 Billion |
| 2022 | 1.26% | 8.85% | 0.11x | 1.25x | NT$-1.06 Billion |
| 2023 | -9.99% | -74.14% | 0.11x | 1.25x | NT$-2.36 Billion |
| 2024 | -10.68% | -63.89% | 0.12x | 1.35x | NT$-2.13 Billion |
| 2025 | -8.50% | -40.01% | 0.15x | 1.38x | NT$-1.65 Billion |
Industry Comparison
This section compares Microbio Co Ltd's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $26,262,476,200
- Average return on equity (ROE) among peers: 5.06%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Microbio Co Ltd (4128) | NT$10.20 Billion | -4.31% | 0.21x | $273.33 Million |
| Wei Chuan Foods Corp (1201) | $3.37 Billion | 0.00% | 2.77x | $198.50 Million |
| Ve Wong Corp (1203) | $5.15 Billion | 5.18% | 0.61x | $323.15 Million |
| Great Wall Enterprise Co Ltd (1210) | $35.47 Billion | 10.22% | 1.15x | $1.45 Billion |
| Charoen Pokphand Enterprise Taiwan Co Ltd (1215) | $2.36 Billion | 0.12% | 0.82x | $1.08 Billion |
| Uni-President Enterprises Corp (1216) | $195.21 Billion | 9.39% | 2.41x | $13.61 Billion |
| AGV Products Corp (1217) | $7.40 Billion | 2.72% | 0.87x | $154.09 Million |
| Taisun Enterprise Co Ltd (1218) | $3.86 Billion | 5.19% | 1.17x | $275.03 Million |
| Fwusow Industry Co Ltd (1219) | $4.43 Billion | 7.26% | 1.32x | $135.46 Million |
| Tai Roun Products Co Ltd (1220) | $1.69 Billion | 0.00% | 0.47x | $65.02 Million |
| Formosa Oilseed Processing Co Ltd (1225) | $3.68 Billion | 10.47% | 0.81x | $251.88 Million |
About Microbio Co Ltd
Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. It also involved in the trading of organic foods; sale of beverages; pr… Read more